{
    "2018-02-27": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Top Pharma Stocks With Dividend Yields Over 3%",
                "features": {
                    "keywords": [
                        "pharma",
                        "dividend yields",
                        "stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "mixed feedback",
                        "cancer treatments",
                        "CHMP"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock soaring",
                        "reasons"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "ABBV Crosses Above Average Analyst Target",
                "features": {
                    "keywords": [
                        "ABBV",
                        "crosses above",
                        "analyst target"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}